Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Cardiac resynchronization therapy devices (CRT)
Implantable cardioverter defibrillators (ICD)
Leads, implantable devices
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
University of Colorado Hospital
Henry Ford Hospital
Baylor Scott and White Heart Hospital
3200 Lakeside Dr.
Santa Clara, CA 95054
Embolic Protection Devices
Stents Drug Eluting
Vascular Closure Devices
Stents Bare Metal
November 15, 2011
New Data Reinforce Clinical Performance of Absorb Bioresorbable Stent
November 15, 2011 – Abbott announced positive long-term data from the two-stage ABSORB trial, which is evaluating the...
November 14, 2011
Comparison of Xience V, Resolute Stents Shows Similar, Low Rates of Thrombosis
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real-...
November 10, 2011
MitraClip Offers Significant Improvements for Both Functional, Degenerative MR in High-Risk Patients
November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral...
November 08, 2011
Economic Study Demonstrates Cost-Effectiveness Of Impella Presented At TCT 2011
November 8, 2011 – Abiomed, a provider of heart support technologies, announced results of an economic study at the...
November 07, 2011
Abbott Presents New Data for Key Vascular Products at TCT 2011
November 7, 2011 – Abbott announced the company's schedule of key data presentations at the 23rd annual Transcatheter...
November 02, 2011
FDA Clears Xience Prime Coronary Stent
The U.S. Food and Drug Administration (FDA) granted market clearance for the Xience Prime everolimus-eluting coronary...
October 18, 2011
Wall Street Journal Award Recognizes Abbott’s Absorb Stent
October 18, 2011 — Abbott announced the investigational Absorb bioresorbable vascular scaffold (BVS) has been...
October 11, 2011
| Dave Fornell
Abbott Wants to Prove Stents Trump CABG
The Holy Grail sought for more than two decades by interventional cardiology has been proof that minimally invasive,...
October 04, 2011
Abbott Enrolls First U.S. Patient in Trial Comparing Xience to CABG
Abbott began enrolling U.S. patients in the EXCEL trial, which will compare the use of the Xience Prime or Xience V...
September 26, 2011
| Dave Fornell
Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends
There have been several key news items from the U.S. stent market over the past year. These include the introduction of...
Scranton Gillette Communications
. All Rights Reserved.
Topics We Cover
Terms and Conditions